Establishment and characterization of therapy-resistant mantle cell lymphoma cell lines derived from diff erent tissue sites

References

• Bertoni F, Ponzoni M. The cellular origin of mantle cell lymphoma. Int J Biochem Cell Biol 2007;39:1747–1753.
   PubMed Web of Science ®Google Scholar
• Gao J, Peterson L, Nelson B, . Immunophenotypic variations in mantle cell lymphoma. Am J Clin Pathol 2009;132:699–706.
   PubMed Web of Science ®Google Scholar
• Zucca E, Stein H, Coiffier B. European Lymphoma Task Force (ELTF): report of the workshop on mantle cell lymphoma (MCL). Ann Oncol 1994;5:507–511.
   PubMed Web of Science ®Google Scholar
• Jares P, Colomer D, Campo E. Genetic and molecular pathogenesis of mantle cell lymphoma: perspectives for new targeted therapeutics. Nat Rev Cancer 2007;7:750–762.
   PubMed Web of Science ®Google Scholar
• Dreyling M, Hiddemann W. Current treatment standards and emerging strategies in mantle cell lymphoma. Hematology 2009:1; 542–551.
   Google Scholar
• Ghielmini M, Zucca E. How I treat mantle cell lymphoma. Blood 2009;114:1469–1476.
   PubMed Web of Science ®Google Scholar
• Foran JM, Cunningham D, Coiffier B, . Treatment of mantle-cell lymphoma with rituximab (chimeric monoclonal anti-CD20 antibody): analysis of factors associated with response. Ann Oncol 2000;11:117–121.
   PubMed Web of Science ®Google Scholar
• Fisher RI, Bernstein SH, Kahl BS, . Multicenter phase II study of bortezomib in patients with relapsed or refractory mantle cell lymphoma. J Clin Oncol 2006;24:4867–4874.
   PubMed Web of Science ®Google Scholar
• Habermann TM, Lossos IS, Justice G, . Lenalidomide oral monotherapy produces a high response rate in patients with relapsed or refractory mantle cell lymphoma. Br J Haematol 2009;145:344–349.
   PubMed Web of Science ®Google Scholar
• Dreyling M, Lenz G, Hoster E, . Early consolidation by myeloablative radiochemotherapy followed by autologous stem cell transplantation in first remission significantly prolongs progression-free survival in mantle-cell lymphoma: results of a prospective randomized trial of the European MCL Network. Blood 2005;105:2677–2684.
   PubMed Web of Science ®Google Scholar
• Jares P, Campo E. Advances in the understanding of mantle cell lymphoma. Br J Heamatol 2008;142:149–165.
   PubMed Web of Science ®Google Scholar
• Kurtova AV, Tamayo AT, Ford RJ, . Mantle cell lymphoma cells express high levels of CXCR4, CXCR5, and VLA-4 (CD49d): importance for interactions with the stromal microenvironment and specific targeting. Blood 2009;113:4604–4613.
   PubMed Web of Science ®Google Scholar
• Coupland SE. The challenge of the microenvironment in B-cell lymphomas. Histopathology 2011;58:69–80.
   PubMed Web of Science ®Google Scholar
• Lai R, McDonnell TJ, O’Connor SL, . Establishment and characterization of a new mantle cell lymphoma cell line, Mino. Leuk Res 2002;26:849–855.
   PubMed Web of Science ®Google Scholar
• Rudolpha C, Steinemanna D, von Neuhoffa N, . Molecular cytogenetic characterization of the mantle cell lymphoma cell line GRANTA-519. Cancer Genet Cytogenet 2004;153:144–150.
   PubMed Web of Science ®Google Scholar
• Jeon HJ, Kim CW, Yoshino T, . Establishment and characterization of a mantle cell lymphoma cell line. Br J Haematol 1998;102:1323–1326.
   PubMed Web of Science ®Google Scholar
• Amin HM, McDonnell TJ, Medeiros LJ, Characterization of 4 mantle cell lymphoma cell lines. Arch Pathol Lab Med 2003;127:424–431.
   PubMed Web of Science ®Google Scholar
• Joshi SS, Sharp JG, Brunson KW. Differential growth characteristics of low and high metastatic variant RAW117 murine lymphosarcoma cells. Oncology 1987;44:180–185.
   PubMed Web of Science ®Google Scholar
• Dave BJ, Nelson M, Sanger WG. Lymphoma cytogenetics. Clin Lab Med 2011;31:725–761.
   PubMed Web of Science ®Google Scholar
• Joshi AD, Hegde GV, Dickinson JD, . ATM, CTLA4, MNDA, and HEM1 in high versus low CD38 expressing B-cell chronic lymphocytic leukemia. Clin Cancer Res 2007;13:5295–5304.
   PubMed Web of Science ®Google Scholar
• Tusher VG, Tibshirani R, Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA 2004;98:5116–5121.
   Web of Science ®Google Scholar
• Subramanian A, Tamayo P, Mootha VK, . Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA 2005;102:15545–15550.
   PubMed Web of Science ®Google Scholar
• Hegde GV, Nordgren TM, Munger CM, . Novel therapy for therapy-resistant mantle cell lymphoma: multipronged approach with targeting hedgehog signalling. Int J Cancer 2012 Apr 17. [Epub ahead of print]
   Google Scholar
• Golardi N, Velasco MR, Elghetany MT. Marginal zone variant of mantle cell lymphoma: CD5-negative cyclin D1-positive variant posing a diagnostic dilemma. Pathol Int 2009;59:317–321.
   PubMed Web of Science ®Google Scholar
• Zapata M, Budnick SD, Bordoni R, . An uncommon case of de novo CD10 + CD5- mantle cell lymphoma mimics follicle center B cell lymphoma. Int J Clin Exp Pathol 2010;3:430–436.
   PubMed Web of Science ®Google Scholar
• Lai R, Weiss LM, Chang KL, . Frequency of CD43 expression in non-Hodgkin lymphoma. A survey of 742 cases and further characterization of rare CD43 + follicular lymphomas. Am J Clin Pathol 1999;111:488–494.
   PubMed Web of Science ®Google Scholar
• Schlette E, Fu K, Medeiros LJ. CD23 expression in mantle cell lymphoma: clinicopathologic features of 18 cases. Am J Clin Pathol 2003;120:760–766.
   PubMed Web of Science ®Google Scholar
• Yasuhara T, Okamoto A, Kitagawa T, . FGF7-like gene is associated with pericentric inversion of chromosome 9, and FGF7 is involved in the development of ovarian cancer. Int J Oncol 2005;26:1209–1216.
   PubMed Web of Science ®Google Scholar
• Haddadin MH, Hawkins AL, Long P, . Cytogenetic study of malignant triton tumor: a case report. Cancer Genet Cytogenet 2003;144:100–105.
   PubMed Web of Science ®Google Scholar
• Rao PH, Houldsworth J, Dyomina K, . Chromosomal and gene amplification in diffuse large B-cell lymphoma. Blood 1998;92:234–240.
   PubMed Web of Science ®Google Scholar
• Camps J, Salaverria I, Garcia MJ, . Genomic imbalances and patterns of karyotypic variability in mantle-cell lymphoma cell lines. Leuk Res 2006;30:923–934.
   PubMed Web of Science ®Google Scholar
• Hao S, Sanger W, Onciu M, . Mantle cell lymphoma with 8q24 chromosomal abnormalities: a report of 5 cases with blastoid features. Mod Pathol 2002;15:1266–1272.
   PubMed Web of Science ®Google Scholar
• Zhao JJ, Lin J, Lwin T, . MicroRNA expression profile and identification of miR-29 as a prognostic marker and pathogenetic factor by targeting CDK6 in mantle cell lymphoma. Blood 2010;115:2630–2639.
   PubMed Web of Science ®Google Scholar
• Wlodarska I, Dierickx D, Vanhentenrijk V, . Translocations targeting CCND2, CCND3, and MYCN do occur in t(11;14)-negative mantle cell lymphomas. Blood 2008;111:5683–5690.
   PubMed Web of Science ®Google Scholar
• Enjuanes A, Fernandez V, Hernandez L, . Identification of methylated genes associated with aggressive clinicopathological features in mantle cell lymphoma. PLoS One 2011;6:e19736.
   PubMed Web of Science ®Google Scholar
• Ripperger T, von Neuhoff N, Kamphues K, . Promoter methylation of PARG1, a novel candidate tumor suppressor gene in mantle cell lymphomas. Haematologica 2007;92:460–468.
   PubMed Web of Science ®Google Scholar
• Leshchenko V, Kuo P, Shaknovich R, . Genomewide DNA methylation analysis reveals novel targets for drug development in mantle cell lymphoma. Blood 2010;116:1025–1034.
   PubMed Web of Science ®Google Scholar